Return to top of page

Rally for Access

Published March 24, 2022

In June 2021, the Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease–the first new therapy Alzheimer’s therapy in almost 20 years. But in January 2022, the Centers for Medicare and Medicaid Services (CMS) announced it has no plans to cover the treatment for most seniors. Even worse, CMS’ decision will extend to future FDA approved Alzheimer’s treatments in this class of drugs. So on March 15, 2022, patients and advocates gathered to make sure their voices were heard. This video shares highlights from the rally.

Related Alzheimer’s Disease Videos

Watch video

Shake the Stigma of Neuropsychiatric Symptoms, Explained in 30 Seconds

Diseases and injuries that damage the brain can impact how we interact with the world and lead to significant and…

more.
Watch video

Shake the Stigma of Neuropsychiatric Symptoms, Explained in 60 Seconds

Diseases and injuries that damage the brain can impact how we interact with the world and lead to significant and…

more.
Watch video

Getting Up to Date on Vaccinations: It’s Our Best Shot

The pandemic has been stressful for everyone, especially older adults. Thankfully, COVID-19 vaccines have allowed us to reunite with…

more.